<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Implanted cardioverter defibrillators (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICDs</z:e>) are an essential part of the management for patients at risk for life threatening <z:hpo ids='HP_0011675'>arrhythmias</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Despite new technologies, <z:hpo ids='HP_0000001'>all</z:hpo> patients ultimately will reach the end of their lives, either because of underlying <z:e sem="disease" ids="C0018799" disease_type="Disease or Syndrome" abbrv="">cardiac disease</z:e> or another <z:e sem="disease" ids="C0679247" disease_type="Disease or Syndrome" abbrv="">terminal illness</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Having an <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> at the end of life may deny a patient the chance of <z:hpo ids='HP_0001645'>sudden cardiac death</z:hpo> and result in a slower <z:e sem="disease" ids="C0679247" disease_type="Disease or Syndrome" abbrv="">terminal disease</z:e> and pain and <z:hpo ids='HP_0000739'>anxiety</z:hpo> due to shocks from their device </plain></SENT>
<SENT sid="3" pm="."><plain>The purpose of this article is to present a focused literature review on the barriers surrounding deactivation of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICDs</z:e> and to summarize the recommendations of the Heart Rhythm Society Consensus Statement on the management of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICDs</z:e> in patients nearing end of life or requesting withdrawal of therapy </plain></SENT>
</text></document>